 The results of this study suggest that the presence of diabetic neuropathy, DN, in Mexican patients with type 2 diabetes, T2D, is strongly associated with several risk factors such as longer duration of T2D, higher glycemic exposure index, low and high density lipid levels, metformin treatment, diabetic retinopathy, and smoking. These findings highlight the importance of identifying these risk factors in order to develop effective prevention strategies and reduce the burden of DN in Mexican patients with T2D. This article was authored by Katie Essay with Tildon Sheposis, Jasmine Monresca Tia, Joel Jamie Santoyo, and others.